FDA Approved: IRESSA — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

This record documents the original FDA approval of IRESSA (gefitinib) by AstraZeneca for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

ORIG AP for IRESSA (GEFITINIB)